Folic acid supplementation in thalassemia patients receiving regular blood transfusions
Phase 4
- Conditions
- Health Condition 1: D561- Beta thalassemia
- Registration Number
- CTRI/2020/03/023895
- Lead Sponsor
- niversity college of Medical Sciences and Guru Teg Bahadur Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Transfusion dependent thalassemia major patients aged 5 to 18 years will be included
Exclusion Criteria
Patients deficient in folate and Vit. B12, splenectomized patients, patients with chronic liver disease, Hepatitis B or C infection, patients taking medicines affecting folate metabolism (cotrimoxazole or methotrexate) will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method